📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

BCR-ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein. (2014)

First Author: Buffa P

Attributed to: Rigorous Information-theoretic tools for Comparative Interactomics. funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1096/fj.13-236992

PubMed Identifier: 24297701

Publication URI: http://europepmc.org/abstract/MED/24297701

Type: Journal Article/Review

Volume: 28

Parent Publication: FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Issue: 3

ISSN: 0892-6638